Gujarat Terce Laboratories P/E Ratio
Current P/E Ratio
11.42
Low Valuation
Low - May indicate good value opportunity
Gujarat Terce Laboratories (GUJTERC) P/E ratio is 11.42 (Low), EPS (TTM) ₹2.92, current price ₹33.35 on BSE — Low - May indicate good value opportunity. Read GUJTERC dividend track record for the complete payout history and dividend yield track record.
Current Valuation Metrics
P/E Ratio
11.42
Current Price
₹33.35
EPS (TTM)
₹2.92
Exchange
BSE
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
55.25
Sector Median
31.04
Sector Rank
#11 of 195
Sector Percentile
5.6%
Earnings Breakdown (TTM)
TTM EPS
₹2.15
Sept 2021
₹0.61
Jun 2021
₹2.16
GUJTERC P/E Ratio — Valuation Signal & Historical Context
Gujarat Terce Laboratories P/E 11.42 — signal: Undervalued. See Gujarat Terce Laboratories P/B ratio trends to compare market price against book value per share.
- Stock appears undervalued with PE of 11.42, suggesting potential buying opportunity
- Trading at discount to sector average PE of 55.25
GUJTERC vs Healthcare Peers — P/E Ratio Comparison
Gujarat Terce Laboratories P/E 11.42 vs Healthcare average 55.25, median 31.04 — range 2.86–987.08.
Sector Average
55.25
Sector Median
31.04
Lowest P/E
2.86
Highest P/E
987.08
Companies
195
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Sunrest Lifescience | SUNREST | 3.65 | ₹29 | Low |
| Phaarmasia | PHRMASI | 3.84 | ₹68 | Low |
| JFL Life Sciences | JFLLIFE | 4.64 | ₹59 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.69 | ₹7,502 | Low |
| Shelter Pharma | SHELTER | 5.32 | ₹50 | Low |
| Mono Pharmacare | MONOPHARMA | 6.02 | ₹19 | Low |
| Royal Sense | ROYAL | 7.4 | ₹51 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹79 | Low |
| Amwill Health Care | AMWILL | 7.71 | ₹88 | Low |